aminoglutethimide ag sold brand names elipten cytadren orimeten among others medication used treatment seizures cushings syndrome breast cancer prostate cancer among also used bodybuilders athletes men musclebuilding performance physiqueenhancing ag taken mouth three four times per side effects ag include lethargy somnolence dizziness headache appetite loss skin rash hypertension liver damage adrenal insufficiency among ag anticonvulsant steroidogenesis terms latter property inhibits enzymes cholesterol sidechain cleavage enzyme aromatase thereby inhibiting conversion cholesterol steroid hormones blocking production androgens estrogens glucocorticoids among endogenous ag aromatase inhibitor adrenal steroidogenesis inhibitor including androgen synthesis inhibitor corticosteroid synthesis ag introduced medical use anticonvulsant withdrawn due steroidogenesisinhibiting properties discovered serendipitously subsequently repurposed use treatment cushings syndrome breast cancer prostate cancer however although used past mostly superseded newer agents better efficacy lower toxicity ketoconazole abiraterone acetate aromatase remains marketed ag used anticonvulsant treatment petit mal epilepsy steroidogenesis inhibitor treatment cushings syndrome postmenopausal breast cancer prostate also used treat secondary hyperaldosteronism edema adrenocortical carcinoma ectopic adrenocorticotropic hormone acth producing used steroidogenesis inhibitor treat breast cancer prostate cancer ag given combination hydrocortisone prednisone equivalent corticosteroid prevent adrenal ag second thirdline choice treatment hormonesensitive metastatic breast cancer effective treatment breast cancer postmenopausal women effective premenopausal women effective ovarian steroidogenesis inhibitor probably potent enough aromatase medication effective treatment prostate cancer effectiveness low inconsistent likely due relatively weak steroidogenesis inhibition poor nonetheless ag found nonsignificantly different effectiveness surgical adrenalectomy terms prostate cancer tumor case ag recommended firstline therapy prostate cancer instead secondline rarely used treatment prostate ag used adrenal steroidogenesis inhibition mouth dosage mg three times per day mgday total first weeks therapy increased mg four times per day mgday total used dosage mg four times per day used aromatase inhibitor inhibit peripheral estrogen production mouth dosage mg twice per day mgday total without significant suppression adrenal steroidogenesis maximal aromatase inhibition said occur dosages mg per side effects ag less frequent severe however still less ag combined hydrocortisone ag generally combined corticosteroid even lower ag used close medical supervision laboratory tests including thyroid function baseline hematological serum glutamicoxaloacetic transaminase alkaline phosphatase ketoconazole achieve similar decreases steroid hormone levels ag effective promoting tumor regression moderately less toxic ag still useful alternative failed unable tolerate ketoconazole therapies ag provided commonly form mg ag used bodybuilders athletes men lower circulating levels cortisol body thereby prevent muscle cortisol catabolic protein muscle effective suppression cortisol ag high doses prevent muscle usually used combination anabolic steroid avoid androgen however usefulness ag purposes questioned users reportedly positive comments risks ag said case ag also used bodybuilders men actions aromatase inhibitor order decrease estrogen said useful inhibiting estrogenic side effects certain anabolic steroids gynecomastia increased water retention fat ag used people known hypersensitivity used women pregnant potential contraindications include chicken pox shingles herpes zoster infection kidney disease liver disease ag many side effects relatively toxic medication although side effects described usually relatively side effects ag include lethargy fatigue weakness malaise drowsiness somnolence depression apathy sleep disturbances stomach discomfort nausea vomiting ataxia joint aches pains fever skin rash hypotension hypertension high cholesterol levels virilization hypothyroidism thyroid abnormalities elevated liver enzymes jaundice hepatotoxicity weight gain leg cramps personality changes blood dyscrasias adrenal insufficiency eg hyponatremia hypoglycemia lethargy common side effect found occur people treated common reason discontinuation skin rash hypotension observed least one side effect occur severe toxicity seen people including circulatory collapse thought due adrenal hematological bone marrow toxicity including marked depression white blood cell count platelets occurs rarely incidence usually seen within first weeks treatment resolves within weeks following ag discontinued people due intolerable side central nervous system side effects ag due nature anticonvulsant relation event overdose ag drowsiness nausea vomiting hypotension respiratory depression may medical attention sought treatment ag overdose include gastric lavage decrease absorption dialysis enhance ag interaction enhances metabolism dexamethasone hydrocortisone used person taking warfarin dosage warfarin may need alcohol potentiates central nervous system side effects dosages theophylline digitoxin medroxyprogesterone acetate may need ag potent nonselective steroidogenesis inhibitor acting reversible competitive inhibitor multiple steroidogenic enzymes ag estrogen synthesis inhibitor adrenal steroidogenesis inhibitor including androgen synthesis inhibitor corticosteroid synthesis reasons ag functional antiestrogenic antiandrogenic antiglucocorticoid antimineralocorticoid terms actions adrenal steroidogenesis inhibitor described form reversible medical adrenalectomy chemical ag inhibits enzymes listed inhibition primarily responsible inhibition adrenal terms adrenal androgens ag shown significantly suppress dehydroepiandrosterone sulfate androstenedione testosterone dihydrotestosterone levels although potent inhibiting aromatase among enzymes targets ag described nonetheless relatively weak aromatase addition described much potent aromatase inhibitor adrenal steroidogenesis ag inhibit aromatase decrease circulating estradiol levels men postmenopausal ag effective ovarian steroidogenesis inhibitor premenopausal however interference ovarian steroidogenesis ag may case result hyperandrogenism virilization premenopausal oral administration absorption ag rapid welldistributed throughout terms metabolism portion ag acetylated biological halflife ag excreted urine ag nonsteroidal compound specifically glutarimide derivative also known chemical names aside glutethimide ag structurally related rogletimide pyridoglutethimide thalidomide well amphenone b metyrapone ag introduced medical use anticonvulsant reported ag induced symptoms addisons disease adrenal insufficiency young following additional reports determined ag acts steroidogenesis discovery ag steroidogenesis inhibitor medication withdrawn market due adverse first report ag treatment breast cancer published first report ag treatment prostate cancer published medication one first adrenal steroidogenesis inhibitors well first aromatase inhibitor discovered used clinically led development aromatase along testolactone described firstgeneration aromatase ag largely superseded medications better effectiveness tolerability reduced toxicity ketoconazole abiraterone acetate aromatase aminoglutethimide generic name drug inntooltip international nonproprietary name usantooltip united states adopted name bantooltip british approved name aminoglutéthimide dcftooltip dénomination commune française aminoglutetimide dcittooltip denominazione comune also known developmental code names ba ciba ag marketed brand names including elipten cytandren also marketed brand names aminoblastin rodazol mamomit among numerous ag appears remain marketed countries include china egypt previously ag available widely throughout world including two dozen countries numerous brand among places marketed united states canada united kingdom european countries australia new zealand south africa south america israel malaysia hong httpsenwikipediaorgwikiaminoglutethimide